Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
1995-5-23
pubmed:abstractText
The roles of outer membrane permeability and Bush group 1 beta-lactamase activity in determining Enterobacter cloacae susceptibility to either meropenem or imipenem were investigated. A beta-lactamase-deficient strain was obtained by mutagenesis from a clinical isolate of E. cloacae, and a porin-deficient strain was selected from this mutant with cefoxitin. Both strains were transformed with the plasmid pAA20R, which contained the gene coding for the carbapenem-hydrolyzing CphA beta-lactamase, and the carbapenem permeability coefficients were measured by the Zimmermann and Rosselet technique (W. Zimmermann and A. Rosselet, Antimicrob. Agents Chemother. 12:368-372, 1977). The permeability coefficient of meropenem was roughly half that of imipenem in the normally permeable strain and almost seven times lower than that of imipenem in the porin-deficient strain. In the porin-deficient strain, the virtual absence of porins caused the MICs of meropenem to increase from 8 to 16 times, while it did not affect the MICs of imipenem. Conversely, the beta-lactamase affected imipenem but not meropenem activity: meropenem showed a similar activity in the parent strain and in the beta-lactamase-deficient mutant with both a low- and high-density inoculum, whereas imipenem was 16 times less active against the parent strain when the high-density inoculum was used. It is concluded that outer membrane permeability and stability to group 1 beta-lactamase have different impacts on the activities of meropenem and imipenem against E. cloacae.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/7726496-1286572, http://linkedlifedata.com/resource/pubmed/commentcorrection/7726496-1336033, http://linkedlifedata.com/resource/pubmed/commentcorrection/7726496-1416880, http://linkedlifedata.com/resource/pubmed/commentcorrection/7726496-1506344, http://linkedlifedata.com/resource/pubmed/commentcorrection/7726496-1526451, http://linkedlifedata.com/resource/pubmed/commentcorrection/7726496-1656855, http://linkedlifedata.com/resource/pubmed/commentcorrection/7726496-1761444, http://linkedlifedata.com/resource/pubmed/commentcorrection/7726496-1761458, http://linkedlifedata.com/resource/pubmed/commentcorrection/7726496-1929248, http://linkedlifedata.com/resource/pubmed/commentcorrection/7726496-1960118, http://linkedlifedata.com/resource/pubmed/commentcorrection/7726496-2014974, http://linkedlifedata.com/resource/pubmed/commentcorrection/7726496-2014984, http://linkedlifedata.com/resource/pubmed/commentcorrection/7726496-2109581, http://linkedlifedata.com/resource/pubmed/commentcorrection/7726496-2193618, http://linkedlifedata.com/resource/pubmed/commentcorrection/7726496-2318754, http://linkedlifedata.com/resource/pubmed/commentcorrection/7726496-2508541, http://linkedlifedata.com/resource/pubmed/commentcorrection/7726496-2580479, http://linkedlifedata.com/resource/pubmed/commentcorrection/7726496-2658781, http://linkedlifedata.com/resource/pubmed/commentcorrection/7726496-2808204, http://linkedlifedata.com/resource/pubmed/commentcorrection/7726496-2808208, http://linkedlifedata.com/resource/pubmed/commentcorrection/7726496-3086492, http://linkedlifedata.com/resource/pubmed/commentcorrection/7726496-334063, http://linkedlifedata.com/resource/pubmed/commentcorrection/7726496-3873215, http://linkedlifedata.com/resource/pubmed/commentcorrection/7726496-3873897, http://linkedlifedata.com/resource/pubmed/commentcorrection/7726496-3873900, http://linkedlifedata.com/resource/pubmed/commentcorrection/7726496-388356, http://linkedlifedata.com/resource/pubmed/commentcorrection/7726496-4559594, http://linkedlifedata.com/resource/pubmed/commentcorrection/7726496-4581138, http://linkedlifedata.com/resource/pubmed/commentcorrection/7726496-5432063, http://linkedlifedata.com/resource/pubmed/commentcorrection/7726496-6294048, http://linkedlifedata.com/resource/pubmed/commentcorrection/7726496-6345791, http://linkedlifedata.com/resource/pubmed/commentcorrection/7726496-6813310, http://linkedlifedata.com/resource/pubmed/commentcorrection/7726496-6818947, http://linkedlifedata.com/resource/pubmed/commentcorrection/7726496-7009583, http://linkedlifedata.com/resource/pubmed/commentcorrection/7726496-8223659, http://linkedlifedata.com/resource/pubmed/commentcorrection/7726496-8517720
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0066-4804
pubmed:author
pubmed:issnType
Print
pubmed:volume
39
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
350-5
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1995
pubmed:articleTitle
Relative importances of outer membrane permeability and group 1 beta-lactamase as determinants of meropenem and imipenem activities against Enterobacter cloacae.
pubmed:affiliation
Università degli Studi di Verona, Istituto di Microbiologia, Verona, Italy.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't